IGF2: the Achilles' heel of p53-deficiency? - Test2 - elhamkhani - TriplyDB

IGF2: the Achilles' heel of p53-deficiency?

IGF2: the Achilles' heel of p53-deficiency?

http://www.wikidata.org/entity/Q36386438

about

Antitumor mechanisms when pRb and p53 are genetically inactivated.Notch signaling in hepatocellular carcinoma: guilty in association!Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells.

P2860

Q38285170-6490BEF2-01D5-4472-A6F2-3A9295D843C9 Q43239248-2EB3ABAC-8F83-4267-9BCD-44ED012F268B Q54996973-B5ED15B6-C176-4308-B54D-F71EB6E44B7A

P2860

IGF2: the Achilles' heel of p53-deficiency?

http://www.wikidata.org/entity/Q36386438

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

IGF2: the Achilles' heel of p53-deficiency?

@ast

IGF2: the Achilles' heel of p53-deficiency?

@en

type

label

IGF2: the Achilles' heel of p53-deficiency?

@ast

IGF2: the Achilles' heel of p53-deficiency?

@en

prefLabel

IGF2: the Achilles' heel of p53-deficiency?

@ast

IGF2: the Achilles' heel of p53-deficiency?

@en

P1433

Q36386438-C4BAB6FE-EA61-460E-910B-6F6E99F8F1C5

P1476

Q36386438-D85B0EBC-DA4A-4625-A0C3-2B8AD52C7473

P2093

Q36386438-55A00290-508C-4AB3-BEA3-49384719401E

P2860

Q36386438-0F18DCE4-269E-4E47-884B-DCCB0E4E2C93

Q36386438-2A2765AB-8D53-4BBD-9727-E64B6E9EC888

Q36386438-2AC7F8D4-924A-4E5B-824F-593A22C34427

Q36386438-3078FB20-99BD-46B3-92DD-2191338786D7

Q36386438-345E1EE3-5E8D-498D-8B72-F3EB4D35829C

Q36386438-526B821F-853E-4DFF-9C98-42A89F1DE164

Q36386438-7B3D0E9A-1A59-44FC-AE11-1935640C4970

Q36386438-873FD831-A234-4529-8E3C-4EE5A37B282B

Q36386438-88BCD9F2-490A-4F41-8943-8616AA01123E

Q36386438-A63D1295-CEB8-420E-82F1-E88276A98B1A

P304

Q36386438-837F2D42-3FD9-45D2-9F92-DB87052381DD

P31

Q36386438-824287AD-161E-46CA-91B9-27BE9E0B01F6

P356

Q36386438-30907102-2761-470A-B251-357F0E61C4ED

P433

Q36386438-39AA752B-1359-43D7-AEC9-18DE2CDB321B

P478

Q36386438-B4C16C6D-EC2E-44FF-AAA0-8F144D6247CB

P50

Q36386438-0521290C-9750-4C17-A171-EF54EFCFA093

Q36386438-2DE95288-AB18-4490-A776-C150B476ABEE

P577

Q36386438-3E152EFD-426F-45F1-8A9D-E439FD3B2BFF

P5875

Q36386438-A04FAFB8-6D8E-4CA6-A8A9-83EB859E80F7

P698

Q36386438-4F70DD37-EB4C-4BEE-A0C4-F942314D3B8C

P932

Q36386438-DA1BB76F-6692-4911-B8ED-5E50065D0972

P356

P1433

EMBO Molecular Medicine

P1476

IGF2: the Achilles' heel of p53-deficiency?

@en

P2093

Frederic Clermont

http://www.w3.org/2001/XMLSchema#string

P2860

p53, the cellular gatekeeper for growth and division

The concept of synthetic lethality in the context of anticancer therapy

H19 acts as a trans regulator of the imprinted gene network controlling growth in mice

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

Tumor spectrum analysis in p53-mutant mice

Awakening guardian angels: drugging the p53 pathway.

Igf2 pathway dependency of the Trp53 developmental and tumour phenotypes.

Insulin receptor isoforms are differently expressed during human osteoblastogenesis.

A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis.

Deregulation of both imprinted and expressed alleles of the insulin-like growth factor 2 gene during beta-cell tumorigenesis.

P304

688-690

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EMMM.201201509

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Christophe Marine

P577

2012-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230565736

http://www.w3.org/2001/XMLSchema#string

P698

22829471

http://www.w3.org/2001/XMLSchema#string

P932

3494069

http://www.w3.org/2001/XMLSchema#string